News
-
January 10, 2011
Critical Path Institute And Clinical Data Interchange Standards Consortium Announce Innovative Partnership To Address Major Diseases
Global leaders join forces to establish data standards and create public data bases as new means to accelerate medical product development -
December 10, 2010
Executive director of Critical Path Institute’s Coalition Against Major Diseases testifies before congress on Alzheimer’s disease progress
Marc Cantillon, MD, presents the critical role of public/private partnerships in creating innovative tools to advance the development of new Alzheimer’s disease -
December 9, 2010
Alfred M. Cohen, MD, FACS, FASCRS, Joins as Director, Cancer Biosignature Programs
Alfred M. Cohen, MD, FACS, FASCRS, has joined Critical Path Institute (C-Path) as Director of its Cancer Biosignature Programs. -
November 10, 2010
Leading Pharmacologist and Pharmaceutical Scientist Joins Critical Path Institute
Thorir D. Bjornsson, MD, PhD, has joined Critical Path Institute as a member of its Board of Directors, and will also lead one of its major consortia, the Critical Path to TB Drug Regimens, Regulatory Science Consortium (CPTR). -
November 10, 2010
Leading Neuroscientist Joins Critical Path Institute
Marc Cantillon, MD, has joined Critical Path Institute as Executive Director of one of its major consortia, the Coalition Against Major Diseases (CAMD). Dr.Cantillon has a 15+year background in government,academic and pharmaceutical industry translational research, drug development and clinical research.